315 related articles for article (PubMed ID: 32121393)
1. Antivirals against Chikungunya Virus: Is the Solution in Nature?
Martins DOS; Santos IA; de Oliveira DM; Grosche VR; Jardim ACG
Viruses; 2020 Feb; 12(3):. PubMed ID: 32121393
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Inhibitor Binding Combined with Reactivity Studies to Discover the Potentially Inhibiting Phytochemicals Targeting Chikungunya Viral Replication.
Rasool N; Bakht A; Hussain W
Curr Drug Discov Technol; 2021; 18(3):437-450. PubMed ID: 32164512
[TBL] [Abstract][Full Text] [Related]
3. Antiviral Strategies Against Chikungunya Virus.
Abdelnabi R; Neyts J; Delang L
Methods Mol Biol; 2016; 1426():243-53. PubMed ID: 27233277
[TBL] [Abstract][Full Text] [Related]
4. Potential Antivirals: Natural Products Targeting Replication Enzymes of Dengue and Chikungunya Viruses.
Oliveira AF; Teixeira RR; Oliveira AS; Souza AP; Silva ML; Paula SO
Molecules; 2017 Mar; 22(3):. PubMed ID: 28327521
[TBL] [Abstract][Full Text] [Related]
5. Beyond Members of the
Ferreira AC; Reis PA; de Freitas CS; Sacramento CQ; Villas Bôas Hoelz L; Bastos MM; Mattos M; Rocha N; Gomes de Azevedo Quintanilha I; da Silva Gouveia Pedrosa C; Rocha Quintino Souza L; Correia Loiola E; Trindade P; Rangel Vieira Y; Barbosa-Lima G; de Castro Faria Neto HC; Boechat N; Rehen SK; Brüning K; Bozza FA; Bozza PT; Souza TML
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455237
[TBL] [Abstract][Full Text] [Related]
6. Chikungunya virus infections: time to act, time to treat.
Abdelnabi R; Neyts J; Delang L
Curr Opin Virol; 2017 Jun; 24():25-30. PubMed ID: 28414993
[TBL] [Abstract][Full Text] [Related]
7. Antivirals against the Chikungunya Virus.
Battisti V; Urban E; Langer T
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372513
[TBL] [Abstract][Full Text] [Related]
8. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
Rothan HA; Bahrani H; Abdulrahman AY; Mohamed Z; Teoh TC; Othman S; Rashid NN; Rahman NA; Yusof R
Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398
[TBL] [Abstract][Full Text] [Related]
9. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses.
Varghese FS; Kaukinen P; Gläsker S; Bespalov M; Hanski L; Wennerberg K; Kümmerer BM; Ahola T
Antiviral Res; 2016 Feb; 126():117-24. PubMed ID: 26752081
[TBL] [Abstract][Full Text] [Related]
10. Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.
Bouma EM; van de Pol DPI; Sanders ID; Rodenhuis-Zybert IA; Smit JM
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321803
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship study of arbidol derivatives as inhibitors of chikungunya virus replication.
Di Mola A; Peduto A; La Gatta A; Delang L; Pastorino B; Neyts J; Leyssen P; de Rosa M; Filosa R
Bioorg Med Chem; 2014 Nov; 22(21):6014-25. PubMed ID: 25282648
[TBL] [Abstract][Full Text] [Related]
12. Current Strategies for Inhibition of Chikungunya Infection.
Subudhi BB; Chattopadhyay S; Mishra P; Kumar A
Viruses; 2018 May; 10(5):. PubMed ID: 29751486
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of nobiletin against chikungunya virus in vitro.
Lin SC; Chen MC; Li S; Lin CC; Wang TT
Antivir Ther; 2017; 22(8):689-697. PubMed ID: 28406093
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
mBio; 2016 May; 7(3):. PubMed ID: 27222471
[TBL] [Abstract][Full Text] [Related]
15. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents.
Jadav SS; Sinha BN; Hilgenfeld R; Jayaprakash V
Curr Comput Aided Drug Des; 2017 Nov; 13(4):346-361. PubMed ID: 28294048
[TBL] [Abstract][Full Text] [Related]
16. Antiviral therapeutics for chikungunya virus.
Ghildiyal R; Gabrani R
Expert Opin Ther Pat; 2020 Jun; 30(6):467-480. PubMed ID: 32249636
[No Abstract] [Full Text] [Related]
17. Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission.
Wang YM; Lu JW; Lin CC; Chin YF; Wu TY; Lin LI; Lai ZZ; Kuo SC; Ho YJ
Antiviral Res; 2016 Nov; 135():81-90. PubMed ID: 27742486
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of medicinal herbs for Anti-CHIKV activity.
Raghavendhar S; Tripati PK; Ray P; Patel AK
Virology; 2019 Jul; 533():45-49. PubMed ID: 31082733
[TBL] [Abstract][Full Text] [Related]
19. Chikungunya virus drug discovery: still a long way to go?
Pérez-Pérez MJ; Delang L; Ng LFP; Priego EM
Expert Opin Drug Discov; 2019 Sep; 14(9):855-866. PubMed ID: 31177861
[No Abstract] [Full Text] [Related]
20. Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry.
Henß L; Beck S; Weidner T; Biedenkopf N; Sliva K; Weber C; Becker S; Schnierle BS
Virol J; 2016 Aug; 13(1):149. PubMed ID: 27581733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
